Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dirksen Lehman

This article was originally published in The Gray Sheet

Executive Summary

President Bush announces Jan. 30 his intention to name Senate Health Committee staff health counsel Lehman as a special assistant for legislative affairs for the Senate. Lehman will work as one of the Senate lobbyists in the White House Office of Legislative Affairs, reporting to chief Senate lobbyist Ziad Ojakli, former chief of staff to Sen. Paul Coverdell (R-Ga.). Before joining the Health Committee staff in 1999, Lehman was with Washington lobbying firm Williams & Jensen. The Health Committee has not yet named a replacement

You may also be interested in...



People In Brief

Edwards expands D.C. presence: Dirksen Lehman and Barry Liden are heading up Edwards Lifesciences' Washington, D.C., government affairs office, the firm announces Oct. 26. Lehman, the new VP-government affairs, joins Edwards from consulting firm Clark & Weinstock, where he led the health care practice. He previously served as special assistant to the President for legislative affairs as the White House's primary liaison to the Senate for health care issues (1"The Gray Sheet" Feb. 5, 2001, p. 24). Liden, director for government affairs, joined the firm in 2002. He previously was director of external communications and most recently directed the firm's state government affairs operations from the Irvine, Calif., headquarters. Edwards says the D.C. office will support the company's growing role in AdvaMed, of which CEO Michael Mussallem becomes chairman in 2008 (2"The Gray Sheet" March 12, 2007, In Brief)

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014436

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel